JPH0124762B2 - - Google Patents

Info

Publication number
JPH0124762B2
JPH0124762B2 JP18511381A JP18511381A JPH0124762B2 JP H0124762 B2 JPH0124762 B2 JP H0124762B2 JP 18511381 A JP18511381 A JP 18511381A JP 18511381 A JP18511381 A JP 18511381A JP H0124762 B2 JPH0124762 B2 JP H0124762B2
Authority
JP
Japan
Prior art keywords
water
tablet
tablets
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP18511381A
Other languages
Japanese (ja)
Other versions
JPS5885804A (en
Inventor
Tokuyuki Taniguchi
Masanori Oota
Hitoshi Sasahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP18511381A priority Critical patent/JPS5885804A/en
Publication of JPS5885804A publication Critical patent/JPS5885804A/en
Publication of JPH0124762B2 publication Critical patent/JPH0124762B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、ジクロロイソシアヌール酸のアルカ
リ金属塩の無水塩と2水塩を主成分として含み、
1錠の重さが約0.2〜5g程度の水中迅速溶解性
の殺菌漂白用小型錠剤に関する。 従来より、トリクロロイソシアヌール酸、ジク
ロロイソシアヌール酸、ジクロロイソシアヌール
酸のアルカリ金属塩の無水塩、含水塩等は水中で
次亜塩素酸等有効塩素を放出するために殺菌漂白
剤として用いられているが、粉状物は使用時に粉
立ち易く、計量も容易でないために次第に使われ
なくなり、代つて顆粒品、錠剤等が主として用い
られている。しかし、上記塩素化イソシアヌール
酸類は、それぞれ異つた物性を示し、例えば、ト
リクロロイソシアヌール酸は水中溶解度及び溶解
速度共に小さく、迅速溶解型の錠剤には適さな
い。迅速溶解型の塩素化イソシアヌール酸錠剤と
しては、ジクロロイソシアヌール酸ナトリウムの
2水塩を加圧成形したものが特開昭50−48116号
公報に示されているが、この錠剤は保存中に、密
閉下でも特に外気温の上昇等により温度上昇が起
こると、結晶水が遊離水に変じ、分解の原因とな
つたり、また、錠剤がもろくなり、運搬、輸送中
に崩壊し易い等の欠点がある。更にジクロロイソ
シアヌール酸ナトリウムの2水塩の粉末は、成形
に供される前に昇温が起こるとやはり結晶水が遊
離水に変じ、粉末の流動性を喪失させ成形を困難
ならしめ、良好な錠剤も得難いことが多い。迅速
溶解型の塩素化イソシアヌール酸錠剤の別の例と
しては、ジクロロイソシアヌール酸ナトリウムの
無水塩を加圧成形したものも知られているが、こ
の無水塩の粉末は成形時金型に付着し易く、打錠
機を特に長時間連続運転させるには、きしみ音発
生の原因となつたり、成形圧を一定に保てなくな
つたり、機械の円滑運転の妨げとなる他、殊にこ
の無水塩の粒子間結合力が乏しいために、得られ
た錠剤は包装容器中でくずれ易いという欠点があ
る。更に別の例としては、ジクロロイソシアヌー
ル酸ナトリウムの無水塩100重量部とジクロロイ
ソシアヌール酸ナトリウムの2水塩又は1水塩
120重量部以上とオルト硼酸0.3〜1重量部からな
る大型の錠剤が特開昭53−136520号公報に提案さ
れているが、同公報に提案の錠剤は、ジクロロイ
ソシアヌール酸ナトリウムの無水塩の吸水膨潤現
象を利用した水中迅速崩壊性錠剤の提供を目的と
したものであり、錠剤の緻密化及び包装容器中特
に輸送時振動等によるくずれを防ぐことが解決さ
れておらず、更に小型錠剤の提供を目的としたも
のでなく、同公報提案の方法により得た0.2〜5
g程度の錠剤は包装容器中振動等によるくずれが
生じ易い。また輸送時のくずれを防止するために
錠剤の緻密化を図ると水中において極端に吸水膨
潤性を失ない迅速な溶解を達成できない。 上記の如く、従来の迅速溶解性の塩素化イソシ
アヌール酸錠剤は、主たる用途として遊泳用プー
ル水等多量の水中投入用に成形されたものであ
り、保存包装容器中で錠剤が若干くずれることが
あつても重大な問題をもたらさない。しかし、迅
速溶解性の塩素化イソシアヌール酸錠剤は、その
実用的安全性と共に優れた殺菌漂白性能が更に広
く認識されるに至り、比較的小量の例えば100
以下の汚水にも適用する要望が種々の分野で発生
しつつあり、それに適する1錠当り約0.2〜5g
程度の緻密でしかも小型のものが望まれている。
かゝる適用分野としては、例えば家庭用浴用水、
壁、天井等を水洗するための水、皮革製品、スポ
ーツ用品等を水洗するための水、調理場における
食器等の洗浄水、金魚鉢、鳥小屋、犬小屋等を水
洗するための水、くし、くつ下等日用品を水洗す
るための水等身近かな不浄対象物を清浄化するた
めの水等が挙げられる。これら清浄化のために用
いられる水中には、通常10ppm以下の有効塩素濃
度となる量の塩素化イソシアヌール酸が供給され
る。例えば、100の水中にはジクロロイソシア
ヌール酸ナトリウムでは、1〜1.5g程度の供給
量となるために、1錠当りの重量としては、0.2
〜2g程度の範囲のものが望まれる。更に、使用
者に1錠当りの重量が表示されるか、単位水量当
りの供給錠剤数が表示されることが多いので、錠
剤が使用前にくづれて1錠当りの重量変化が起つ
たり、錠剤が保存中に変質して有効塩素含有率が
変つたりしないことが望まれる。このように、塩
素化イソシアヌール酸の小型錠剤としては、緻密
であつて保存安定性に優れしかも、水中に投入し
た際、迅速に崩壊して溶解する性質を有すること
が欠かせ得ない。 本発明の目的は、迅速溶解性を示すジクロロイ
ソシアヌール酸ナトリウム又はカリウムの無水塩
とジクロロイソシアヌール酸ナトリウムの2水塩
を主成分として含み、1錠当りの重量が0.2〜5
g程度である緻密な新規小型の殺菌漂白用錠剤を
提供することにある。更に他の目的は、保存中に
変質が起らず、輸送・運搬等による振動によつて
もくずれることのない上記新規な小型の殺菌漂白
用錠剤を提供することにある。本発明の錠剤は、
粒径100〜2000μのジクロロイソシアヌール酸ナ
トリウム又はジクロロイソシアヌール酸カリウム
の無水塩100重量部、粒径100〜2000μのジクロロ
イソシアヌール酸ナトリウムの2水塩5〜100重
量部及び粒径250μ以下のタルク又はオルト硼酸
3〜50重量部を主成分として含む均一混合物を加
圧成形してなる密度1.50〜1.95g/cm3の殺菌漂白
用小型錠剤である。 本発明における錠剤の迅速溶解性とは、錠剤を
常温に充分量の水中に投入した際10分以内に溶解
が完了する速さをいう。また、本発明の錠剤の小
型とは、1錠当りの重量が約0.2〜5g程度のも
のをいう。 ジクロロイソシアヌール酸ナトリウムには、1
分子中に2分子の結晶水を含む2水塩と、1分子
の結晶水を含む1水塩と結晶水を全く含まない無
水塩とが知られている。また、ジクロロイソシア
ヌール酸カリウムには、1分子中に1分子の結晶
水を含む1水塩と結晶水を全く含まない無水塩が
知られている。本発明に用いられるものは上記の
うち、ジクロロイソシアヌール酸ナトリウム又は
ジクロロイソシアヌール酸カリウムの無水塩とジ
クロロイソシアヌール酸ナトリウムの2水塩であ
り、市販工業製品で充分である。ジクロロイソシ
アヌール酸ナトリウム又はジクロロイソシアヌー
ル酸カリウムの1水塩は安定性に乏しく、また、
製造も容易でないために本発明に用いるには好ま
しくない。本発明に用いられる上記ジクロロイソ
シアヌール酸ナトリウム又はジクロロイソシアヌ
ール酸カリウムの無水塩及びジクロロイソシアヌ
ール酸ナトリウムの2水塩は、乾燥粉体であつ
て、その粒子径が100〜2000μであることが好ま
しい。この粒子径が100μ以下では、打錠機によ
る連続打錠の際、打錠機の円滑な連続運転の障害
の原因となつたり、また、滑沢剤の増量を要する
ことゝなり好ましくない。また、粒子径が2000μ
以上では、緻密な錠剤に打錠しにくゝなり、更
に、粉体の均一混合物が得にくゝなり、錠剤が水
中で崩壊と溶解を起こす際、その均一性を欠如し
易くなる。本発明に用いられるタルク又はオルト
硼酸(H3BO3)は、滑沢剤の作用をする。その
粒子径は小さい程好ましいが、通常250μ以下の
市販工業製品でよい。粒子径が250μ以上となる
と、添加量の割には打錠時の打錠性向上に効果が
なく、増量を要すこととなり錠剤中の有効塩素濃
度を低下させるので好ましくない。 本発明の錠剤は、上記ジクロロイソシアヌール
酸ナトリウム又はジクロロイソシアヌール酸カリ
ウムの無水塩、ジクロロイソシアヌール酸ナトリ
ウムの2水塩及びタルク又はオルト硼酸の特定比
率の均一混合物を加圧成形することにより得られ
る。上記特定比率とは、上記無水塩100重量部に
対し、上記2水塩5〜100重量部好ましくは10〜
40重量部と、上記滑沢剤3〜50重量部である。上
記2水塩の混合比率が5重量部以下では、均一混
合物の打錠時に、粉末が金型に付着し易くなり、
定常連続成形を困難ならしめ、一定品質の錠剤に
成形し難くなる。更に得られた錠剤も、もろくな
り易い。また、上記2水塩の混合比率が100重量
部以上では、混合物を打錠して得た錠剤が水中に
投入された際、水中での崩壊性に乏しくなり、溶
解時間を長びかせ、迅速溶解性となりにくい。更
に保存中の変質も起こり易くなる。上記滑沢剤の
混合比率は、オルト硼酸では3〜50重量部特に好
ましくは10〜40重量部であり、また、タルクでは
3〜30重量部、特に好ましくは5〜20重量部であ
る。上記滑沢剤の混合比率が下限値以下では、打
錠時混合物の成形性に不足を来たし、また、上限
値以上では、錠剤中の有効塩素濃度を低下せしめ
ることとなり好ましくない。上記特定比率に上記
成分を混合するには、通常の粉体混合機を用いる
ことにより容易に行なわれる。均一な混合によ
り、その混合物から得られる錠剤は品質が一定す
る。本発明に用いられる上記均一混合物として
は、上記成分を上記比率に混合したものの他、本
発明の目的が達成される限り所望の添加剤を更に
混合したものも差支えない。例えば、適当な着色
剤、洗剤等を少量混合すると好ましいこともあ
る。 本発明の錠剤は、上記均一混合物を密度1.5〜
1.95g/cm3となるように加圧成形することにより
得られる。加圧成形の方法としては、通常の打錠
機を用いる方法で充分である。成形圧力は、通常
100〜1000Kg/cm2、特に400〜600Kg/cm2程度が好
ましい。上記均一混合物の粒子径及びその分布と
成形圧力とによつて、得られる錠剤の密度が若干
変動するが、前記粒度の原料を混合した均一混合
物を100〜1000Kg/cm2の圧下成形することにより、
得られた錠剤の密度はほゞ1.50〜1.95g/cm3とな
る。この錠剤の密度は重要な効果を奏し、密度
1.50g/cm3以下では、保存中の振動等によるくず
れが生じ易く、また、密度1.95g/cm3以上に高め
ることは高い成形圧による打錠機の損耗をもたら
し、更に、水中での崩壊性が乏しくなり密度向上
の割には改良効果が得られない。本発明の錠剤が
水中で迅速な崩壊性を示し、かつ、保存容器中で
のくずれが生じない性質を示すことは、上記均一
混合物の粉体粒子の適度な粒度構成により、圧縮
成形時粒子間圧着が起こると共に緻密化が達成さ
れ、しかも、水中で錠剤表面からの水の浸透性が
良好であるために、前記無水塩の吸水膨潤現象が
迅速に生起することによるものと考えられる。 かくして、本発明の錠剤は、密閉下に保存すれ
ば、変質、くずれが起らず、水中での迅速崩壊及
び溶解性を示し、小型の錠剤として水量の少い浄
化すべき水に投入して使用される。性能としては
殺菌、消毒、脱臭、漂白、洗浄力を有するので前
記の如く身近かな生活還境の浄化用に極めて有用
である。以下実施例及び比較例を挙げて説明する
が、本発明の技術的範囲はこれに限定されない。
実施例及び比較例に先達ち、先ず、成形性及び錠
剤性能試験法を記述する。 (1) 成形性 ロータリー式打錠機により連続打錠を行な
い、打錠時きしみ音発生の有無をしらべると共
に、得られた錠剤について、木屋式硬度計によ
る錠剤の硬度、外観性状の観測を行なう。 (2) 錠剤の水中崩壊性 2のビーカー中に1.8の水を投入し、こ
れを30±1℃に調節した後この中へ錠剤を投入
し、その直後から錠剤が完全に崩壊し芯が残ら
なくなる迄の時間を測定する。 (3) 錠剤の保存安定性 錠剤を密閉式ガラスびんに入れた後、これを
35℃の恒温室中に保存し、3ケ月経過時点で錠
剤をとり出し、外観性状を観測する。 実施例及び比較例 第1表記載の配合による均一混合物を、上記ロ
ータリー式打錠機により圧力500Kg/cm2で打錠し、
1錠の重さ0.3g又は1.0gの錠剤に成形し、(表
中**は0.3g、他は1.0gを示す。)その際の成
形性を上記試験法により観測し、更に得られた錠
剤について、上記試験法により水中崩壊性と保存
安定性を測定し第1表記載の結果を得た。 本発明の実施例は成型性、錠剤硬度、外観、水
中崩壊性及び保存安定性に於いて全て良好な結果
を示しているが、粒径が本発明の要件を満してい
ない比較例1は成型時にきしみ音が発生したり、
得られた錠剤の側面に傷が多く、また錠剤の縁部
がかなり崩れていた。
The present invention contains anhydrous salts and dihydrate salts of alkali metal salts of dichloroisocyanuric acid as main components,
The present invention relates to small tablets for sterilization and bleaching that are rapidly soluble in water and each tablet weighs about 0.2 to 5 g. Traditionally, trichloroisocyanuric acid, dichloroisocyanuric acid, anhydrous salts and hydrated salts of alkali metal salts of dichloroisocyanuric acid have been used as disinfectant bleaches to release available chlorine such as hypochlorous acid in water. However, powder products tend to crumble during use and are not easy to measure, so they are gradually no longer used, and instead granules, tablets, etc. are mainly used. However, the above-mentioned chlorinated isocyanuric acids each exhibit different physical properties; for example, trichloroisocyanuric acid has low solubility in water and low dissolution rate, and is not suitable for rapid-dissolving tablets. As a quick-dissolving type chlorinated isocyanuric acid tablet, a pressure-molded tablet of sodium dichloroisocyanurate dihydrate is disclosed in JP-A-50-48116. However, even if the tablet is sealed, if the temperature rises due to an increase in the outside temperature, the water of crystallization may turn into free water, causing decomposition, and the tablet may become brittle and easily disintegrate during transportation. There is. Furthermore, when the temperature of sodium dichloroisocyanurate dihydrate powder is raised before it is subjected to molding, the water of crystallization changes to free water, which causes the powder to lose its fluidity and make molding difficult. Tablets are also often difficult to obtain. Another example of a rapidly dissolving chlorinated isocyanuric acid tablet is one made by pressure molding the anhydrous salt of sodium dichloroisocyanurate, but this anhydrous salt powder adheres to the mold during molding. In particular, when a tablet press is operated continuously for a long period of time, it may cause squeaking noise, make it impossible to maintain a constant molding pressure, and impede the smooth operation of the machine. Due to the poor interparticle bonding strength of the salt, the resulting tablets have the disadvantage of being prone to crumbling in packaging containers. Still another example is 100 parts by weight of the anhydrous salt of sodium dichloroisocyanurate and the dihydrate or monohydrate of sodium dichloroisocyanurate.
A large tablet consisting of 120 parts by weight or more and 0.3 to 1 part by weight of orthoboric acid is proposed in JP-A-53-136520. The purpose is to provide tablets that rapidly disintegrate in water by utilizing water absorption and swelling phenomenon, but problems such as densification of tablets and prevention of collapse due to vibrations in packaging containers, especially during transportation, have not yet been solved, and furthermore, there is a problem with small tablets. 0.2 to 5 obtained by the method proposed in the bulletin, not for the purpose of providing
Tablets weighing about 1.5 oz. are likely to crumble due to vibrations in the packaging container. Furthermore, if the tablet is made denser to prevent it from collapsing during transportation, rapid dissolution without excessive loss of water absorption and swelling properties in water cannot be achieved. As mentioned above, conventional quick-dissolving chlorinated isocyanuric acid tablets are mainly molded for use in large amounts of water such as swimming pool water, and the tablets may crumble slightly in the storage packaging container. Even if it does occur, it will not cause any serious problems. However, rapidly dissolving chlorinated isocyanuric acid tablets have become more widely recognized for their excellent germicidal bleaching performance as well as their practical safety, and their use in relatively small amounts of e.g.
Demand for application to the following wastewater is emerging in various fields, and approximately 0.2 to 5 g per tablet is suitable for this purpose.
There is a need for something that is reasonably precise and compact.
Such fields of application include, for example, household bath water,
Water for washing walls, ceilings, etc., water for washing leather products, sports equipment, etc., water for washing dishes, etc. in the kitchen, water for washing fishbowls, birdhouses, dog houses, etc., combs, Examples include water used to wash daily necessities such as socks, and water used to clean nearby unclean objects. Chlorinated isocyanuric acid is usually supplied to the water used for cleaning in an amount that provides an available chlorine concentration of 10 ppm or less. For example, the amount of sodium dichloroisocyanurate supplied in 100 g of water is about 1 to 1.5 g, so the weight per tablet is 0.2 g.
A range of about 2g is desirable. Furthermore, since the weight per tablet or the number of tablets supplied per unit amount of water is often displayed to the user, the weight of each tablet may change due to the tablet being crushed before use. It is desirable that the available chlorine content of the tablets does not change due to deterioration during storage. As described above, small tablets of chlorinated isocyanuric acid must be dense and have excellent storage stability, and must also have the property of quickly disintegrating and dissolving when placed in water. The object of the present invention is to contain rapidly dissolving sodium or potassium dichloroisocyanurate anhydrous salt and sodium dichloroisocyanurate dihydrate as main components, and the weight per tablet is 0.2 to 5.
An object of the present invention is to provide a novel compact sterilizing bleaching tablet with a density of approximately 1.5 g. Still another object is to provide the above-mentioned novel small-sized sterilizing bleaching tablets that do not undergo deterioration during storage and do not collapse even when subjected to vibrations during transportation. The tablet of the present invention is
100 parts by weight of anhydrous sodium dichloroisocyanurate or potassium dichloroisocyanurate with a particle size of 100 to 2000μ, 5 to 100 parts by weight of sodium dichloroisocyanurate dihydrate with a particle size of 100 to 2000μ, and a particle size of 250μ or less These are small tablets for sterilizing bleaching with a density of 1.50 to 1.95 g/cm 3 made by pressure molding a homogeneous mixture containing 3 to 50 parts by weight of talc or orthoboric acid as a main component. The rapid dissolution of a tablet in the present invention refers to the speed at which dissolution is completed within 10 minutes when the tablet is placed in a sufficient amount of water at room temperature. Moreover, the small size of the tablet of the present invention refers to one having a weight of about 0.2 to 5 g per tablet. Sodium dichloroisocyanurate contains 1
Dihydrate salts containing two molecules of water of crystallization in the molecule, monohydrate salts containing one molecule of water of crystallization, and anhydrous salts containing no water of crystallization are known. Further, potassium dichloroisocyanurate is known to have a monohydrate salt containing one molecule of water of crystallization in one molecule and an anhydrous salt containing no water of crystallization at all. Of the above, those used in the present invention are the anhydrous salt of sodium dichloroisocyanurate or potassium dichloroisocyanurate and the dihydrate salt of sodium dichloroisocyanurate, and commercially available industrial products are sufficient. Sodium dichloroisocyanurate or potassium dichloroisocyanurate monohydrate has poor stability, and
Since it is not easy to manufacture, it is not preferable for use in the present invention. The above-mentioned anhydrous salt of sodium dichloroisocyanurate or potassium dichloroisocyanurate and dihydrate of sodium dichloroisocyanurate used in the present invention are dry powders with a particle size of 100 to 2000μ. preferable. If the particle size is less than 100 μm, it is undesirable because it may cause trouble in the smooth continuous operation of the tablet machine during continuous tablet compression using the tablet machine, or it may require an increase in the amount of lubricant. In addition, the particle size is 2000μ
In this case, it becomes difficult to compress into dense tablets, and furthermore, it becomes difficult to obtain a homogeneous mixture of powder, and when the tablet disintegrates and dissolves in water, it tends to lack uniformity. Talc or orthoboric acid (H 3 BO 3 ) used in the present invention acts as a lubricant. The smaller the particle size is, the more preferable it is, but commercially available industrial products having a particle size of 250 μm or less may be used. If the particle size is 250μ or more, it is not effective in improving the tableting properties during tableting considering the amount added, and the amount needs to be increased, which lowers the effective chlorine concentration in the tablet, which is not preferable. The tablets of the present invention are obtained by pressure molding a homogeneous mixture of the above-mentioned anhydrous salt of sodium dichloroisocyanurate or potassium dichloroisocyanurate, dihydrate of sodium dichloroisocyanurate, and talc or orthoboric acid in a specific ratio. It will be done. The above specific ratio means 5 to 100 parts by weight of the above dihydrate to 100 parts by weight of the above anhydrous salt, preferably 10 to 100 parts by weight.
40 parts by weight, and 3 to 50 parts by weight of the above-mentioned lubricant. If the mixing ratio of the above-mentioned dihydrate salt is 5 parts by weight or less, the powder tends to adhere to the mold when compressing the homogeneous mixture into tablets.
This makes steady continuous molding difficult, making it difficult to form tablets of constant quality. Moreover, the resulting tablets also tend to become brittle. In addition, if the mixing ratio of the above-mentioned dihydrate salt is 100 parts by weight or more, when the tablet obtained by compressing the mixture is put into water, the disintegration in water becomes poor, the dissolution time is prolonged, and the disintegration time is increased. Hardly soluble. Furthermore, deterioration during storage is more likely to occur. The mixing ratio of the lubricant is 3 to 50 parts by weight for orthoboric acid, particularly preferably 10 to 40 parts by weight, and 3 to 30 parts by weight, particularly preferably 5 to 20 parts by weight for talc. If the mixing ratio of the lubricant is below the lower limit, the moldability of the mixture during tableting will be insufficient, and if it is above the upper limit, the effective chlorine concentration in the tablet will be reduced, which is not preferable. Mixing the above components in the above specific ratio can be easily done using a common powder mixer. Uniform mixing ensures that the tablets obtained from the mixture are of consistent quality. The above-mentioned homogeneous mixture used in the present invention may be one in which the above-mentioned components are mixed in the above-mentioned ratios, or may be one in which desired additives are further mixed as long as the object of the present invention is achieved. For example, it may be preferable to mix in small amounts of suitable colorants, detergents, etc. The tablet of the present invention has a density of 1.5 to
Obtained by pressure molding to a weight of 1.95 g/cm 3 . As a method of pressure molding, a method using an ordinary tableting machine is sufficient. Molding pressure is usually
It is preferably about 100 to 1000 Kg/cm 2 , particularly about 400 to 600 Kg/cm 2 . The density of the tablets obtained will vary slightly depending on the particle size and distribution of the above-mentioned uniform mixture and the molding pressure, but by molding a uniform mixture of raw materials with the above-mentioned particle size under pressure of 100 to 1000 kg/cm 2 . ,
The density of the obtained tablets is approximately 1.50 to 1.95 g/cm 3 . The density of this tablet has an important effect, and the density
If the density is less than 1.50 g/cm 3 , it will easily collapse due to vibration during storage, and if the density is increased to 1.95 g/cm 3 or more, it will cause wear and tear on the tablet press due to high molding pressure, and furthermore, it will disintegrate in water. The properties become poor, and no improvement effect can be obtained despite the increase in density. The fact that the tablets of the present invention exhibit rapid disintegration in water and do not collapse in a storage container is due to the appropriate particle size structure of the powder particles of the homogeneous mixture. This is thought to be due to the fact that densification is achieved when compression occurs, and water permeability from the tablet surface is good in water, so that the water absorption and swelling phenomenon of the anhydrous salt occurs rapidly. Thus, the tablets of the present invention do not change in quality or crumble when stored under airtight conditions, exhibit rapid disintegration and solubility in water, and can be placed as small tablets into water to be purified with a small amount of water. used. Since it has sterilizing, disinfecting, deodorizing, bleaching, and cleaning powers, it is extremely useful for purifying everyday living environments as mentioned above. The present invention will be described below with reference to Examples and Comparative Examples, but the technical scope of the present invention is not limited thereto.
Before proceeding to Examples and Comparative Examples, first, the moldability and tablet performance test methods will be described. (1) Formability Continuous tableting is performed using a rotary tablet press, and the presence or absence of squeaking noise during tableting is examined, and the hardness and external appearance of the obtained tablets are observed using a Kiya hardness tester. . (2) Disintegratability of tablets in water Pour 1.8 ml of water into the beaker from step 2, adjust the temperature to 30±1°C, and then put the tablets into the beaker. Immediately after that, the tablets completely disintegrate and no core remains. Measure the time until it disappears. (3) Storage stability of tablets After placing the tablets in an airtight glass bottle,
Store in a constant temperature room at 35°C, take out the tablet after 3 months, and observe the appearance and properties. Examples and Comparative Examples A homogeneous mixture according to the formulation shown in Table 1 was tableted at a pressure of 500 Kg/cm 2 using the above rotary tablet press,
The tablets were molded into tablets each weighing 0.3 g or 1.0 g (in the table, ** indicates 0.3 g, others indicate 1.0 g), and the moldability at that time was observed using the above test method. The tablets were measured for disintegration in water and storage stability using the above test methods, and the results shown in Table 1 were obtained. The examples of the present invention all show good results in moldability, tablet hardness, appearance, disintegration in water, and storage stability, but Comparative Example 1 whose particle size does not meet the requirements of the present invention Creaking noise occurs during molding,
There were many scratches on the side surfaces of the tablets obtained, and the edges of the tablets were considerably collapsed.

【表】 ムを各々表わす。
** 1錠の重さが0.3gであることを表わす。
また、滑沢剤としてステアリン酸ナトリウムを用
いた比較例2では、錠剤の硬度が低く、水中崩壊
性も非常に悪い。ジクロロイソシアヌール酸ナト
リウムの2水塩の量について本発明の要件を満し
ていない比較例3では、打錠時きしみ音が発生
し、得られた錠剤の縁部にくずれが見られた。比
較例4も上記2水塩の量について本発明の要件を
満してないものが、錠剤の水中崩壊時間が長く、
保存安定性も不良である。比較例5、6及び7に
ついても本発明の混合比率の要件を満しておらず
成型性、水中崩壊性または保存安定性について充
分でない。 上記実施例に示す通り、本発明の錠剤は、小型
の殺菌漂白用錠剤として優れた実用性能を有す
る。
[Table] Indicates each mu.
** Indicates that the weight of one tablet is 0.3g.
Furthermore, in Comparative Example 2 in which sodium stearate was used as a lubricant, the hardness of the tablet was low and the disintegration in water was also very poor. In Comparative Example 3, in which the amount of sodium dichloroisocyanurate dihydrate did not meet the requirements of the present invention, squeaks occurred during tablet compression, and deformation was observed at the edges of the resulting tablets. Comparative Example 4 also did not satisfy the requirements of the present invention regarding the amount of dihydrate salt, but the disintegration time in water of the tablet was long;
Storage stability is also poor. Comparative Examples 5, 6, and 7 also did not meet the requirements for the mixing ratio of the present invention, and did not have sufficient moldability, disintegration in water, or storage stability. As shown in the above examples, the tablet of the present invention has excellent practical performance as a small tablet for sterilizing and bleaching.

Claims (1)

【特許請求の範囲】[Claims] 1 粒径100〜2000μのジクロロイソシアヌール
酸ナトリウム又はジクロロイソシアヌール酸カリ
ウムの無水塩100重量部、粒径100〜2000μのジク
ロロイソシアヌール酸ナトリウムの2水塩5〜
100重量部及び粒径250μ以下のタルク又はオルト
硼酸3〜50重量部を主成分として含む均一混合物
を加圧成形してなる密度1.50〜1.95g/cm3の殺菌
漂白用小型錠剤。
1 100 parts by weight of anhydrous salt of sodium dichloroisocyanurate or potassium dichloroisocyanurate with a particle size of 100 to 2000μ, 5 to 5 parts of dihydrate of sodium dichloroisocyanurate with a particle size of 100 to 2000μ
A small tablet for sterilizing bleaching with a density of 1.50 to 1.95 g/cm 3 obtained by pressure molding a homogeneous mixture containing 100 parts by weight and 3 to 50 parts by weight of talc or orthoboric acid with a particle size of 250 μm or less as main components.
JP18511381A 1981-11-18 1981-11-18 Small tablet for bleach sterilization Granted JPS5885804A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18511381A JPS5885804A (en) 1981-11-18 1981-11-18 Small tablet for bleach sterilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18511381A JPS5885804A (en) 1981-11-18 1981-11-18 Small tablet for bleach sterilization

Publications (2)

Publication Number Publication Date
JPS5885804A JPS5885804A (en) 1983-05-23
JPH0124762B2 true JPH0124762B2 (en) 1989-05-15

Family

ID=16165082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18511381A Granted JPS5885804A (en) 1981-11-18 1981-11-18 Small tablet for bleach sterilization

Country Status (1)

Country Link
JP (1) JPS5885804A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471858B (en) * 2009-07-14 2013-12-04 Chemtech Dev Pty Ltd process for preparing a shaped body

Also Published As

Publication number Publication date
JPS5885804A (en) 1983-05-23

Similar Documents

Publication Publication Date Title
US4587031A (en) Process for the production of tablet form detergent compositions
CA1277890C (en) Detergent tablets of uniform composition for dishwashing machines
US3342674A (en) Sterilizing, sanitizing, and/or disinfecting shapes
US5021186A (en) Chloroisocyanuric acid composition having storage stability
IL45584A (en) Strong storage stable chlorine releasing shaped-structure
EP0224135A2 (en) Compact detergents
EP0264701A1 (en) Cleaning agent tablets for the automatic dishwashing
US3755179A (en) Chemical composition
EP0871698B1 (en) Method of producing breakage-resistant detergent tablets
US3276949A (en) Tablets comprising calcium hypochlorite and sodium sulfate and method of preparation
JPH0542404B2 (en)
US3956444A (en) Process for producing a rapidly-soluble sodium dichloroisocyanurate dihydrate tablet
US4024257A (en) Rapidly-soluble sodium dichloroisocyanurate dihydrate tablet
JPH0124762B2 (en)
EP0658190B1 (en) Process for producing detergent tablets
EP0081962A2 (en) Denture cleansing composition
JP4047951B2 (en) Bleached powder composition
JP4925300B2 (en) Chlorinated isocyanuric acid tablets
JPS6352604B2 (en)
JPS59219205A (en) Production of expandable tablet
US3584099A (en) Adipic acid as a tableting lubricant
JPS6141487B2 (en)
JP5985547B2 (en) Floating effervescent tablets
JPH036142B2 (en)
JP3063272B2 (en) Fast soluble chlorinated isocyanuric acid molded article